Knockdown of eIF4E suppresses cell growth and migration, enhances chemosensitivity and correlates with increase in Bax/Bcl-2 ratio in triple-negative breast cancer cells.
about
The fate of chemoresistance in triple negative breast cancer (TNBC)Transcriptomic and proteomic profiling of maize embryos exposed to camptothecinSuppression of eukaryotic initiation factor 4E prevents chemotherapy-induced alopeciaPhosphorylation of eIF4E Confers Resistance to Cellular Stress and DNA-Damaging Agents through an Interaction with 4E-T: A Rationale for Novel Therapeutic Approaches.Phospho-4e-BP1 and eIF4E overexpression synergistically drives disease progression in clinically confined clear cell renal cell carcinomaeIF4F suppression in breast cancer affects maintenance and progressioneIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyond.Dual abrogation of MNK and mTOR: a novel therapeutic approach for the treatment of aggressive cancers.Triple negative breast cancer chemosensitivity and chemoresistance: current advances in biomarkers indentification.Targeting translation: eIF4E as an emerging anticancer drug target.Prognostic significance of eukaryotic initiation factor 4E in hepatocellular carcinoma.Developing anti-neoplastic biotherapeutics against eIF4F.Targeting of protein translation as a new treatment paradigm for prostate cancer.Targeted Dual pH-Sensitive Lipid ECO/siRNA Self-Assembly Nanoparticles Facilitate In Vivo Cytosolic sieIF4E Delivery and Overcome Paclitaxel Resistance in Breast Cancer Therapy.Elevated levels of p-Mnk1, p-eIF4E and p-p70S6K proteins are associated with tumor recurrence and poor prognosis in astrocytomas.Silencing of TGIF sensitizes MDA-MB-231 human breast cancer cells to cisplatin-induced apoptosis.
P2860
Q26775232-51B976BB-118B-4384-85E9-FC7177AB7B8EQ33906015-3ADE5818-6179-4BA9-A8A1-60E3095C23C0Q34479333-F9B5708A-A464-41AC-8A01-D27BBD5318A6Q35553279-754BD803-0C5B-4C2E-9ACB-CA648519F392Q36250674-B5614D67-9DC2-4300-9FF7-C9F9CC17C003Q36892399-C0F25B63-B68A-4CE7-9179-9C55F5D81D87Q37687085-C8D1C948-F6EA-44C1-A961-5A9B5BD053EBQ38227377-527A0DF3-B1CE-43AB-BE00-C7D54F8B80E7Q38637354-AC8DF674-D67F-42FA-87C8-9A582AF0D6D8Q38647802-81DD18F3-99E2-4F6E-A960-0FB99082BDCAQ38699320-46786BEA-C2CC-4DD2-B499-A596F96F021EQ38747860-10E9F9FF-EE99-44F1-9D8F-D4469084B686Q39048156-DDF92554-B708-41D4-B1D2-F4AB47B4F201Q39172901-38483C4D-03EA-4188-B1E4-4542434E666DQ42754623-2DE81FB3-B546-4525-8030-BDB1FCCDAAB6Q48412304-E83741CC-33C3-4F44-9B0A-400FFB20108FQ49875247-14D3E0D7-D982-4099-9BA1-B7362EFFE07D
P2860
Knockdown of eIF4E suppresses cell growth and migration, enhances chemosensitivity and correlates with increase in Bax/Bcl-2 ratio in triple-negative breast cancer cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Knockdown of eIF4E suppresses ...... -negative breast cancer cells.
@en
Knockdown of eIF4E suppresses ...... -negative breast cancer cells.
@nl
type
label
Knockdown of eIF4E suppresses ...... -negative breast cancer cells.
@en
Knockdown of eIF4E suppresses ...... -negative breast cancer cells.
@nl
prefLabel
Knockdown of eIF4E suppresses ...... -negative breast cancer cells.
@en
Knockdown of eIF4E suppresses ...... -negative breast cancer cells.
@nl
P2093
P2860
P1433
P1476
Knockdown of eIF4E suppresses ...... -negative breast cancer cells.
@en
P2093
Fei-fei Zhou
Fei-meng Zheng
Gui-fang Guo
Hui-juan Qiu
Liang-ping Xia
Xiao-feng Zhu
P2860
P2888
P304
P356
10.1007/S12032-010-9630-0
P577
2010-07-22T00:00:00Z